Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Operational Update

29 Jan 2015 07:00

RNS Number : 4400D
Biome Technologies PLC
29 January 2015
 



29 January 2015

 

Biome Technologies plc

("Biome" or "the Company")

 

 

Bioplastics division sees increased demand

 

 

 

Biome Technologies is pleased to announce that its Bioplastics Division has recently received significant orders to the value of approximately £0.4m, for delivery in the first quarter of 2015.

 

In the six months to 30 June 2014 revenues in the Bioplastics Division were £1.1m but declined to £0.3m in the second half to 31 December 2014. This reduction was highlighted in the Company's past two trading statements as being linked to reduced offtake to the single-serve coffee market in the USA. Further, it was explained that demand had been compromised by competitive challenges to the coffee brewing technology of Biome's main customer.

 

The Board noted in its trading statement of 22 January 2015, that whilst this problem had been resolved technically, demand was yet to normalise. The Board believes that the orders, referred to above, are an encouraging indication that normalisation is underway.

 

-Ends-

 

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Allenby Capital

David Hart (Nomad)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDXGDBUGDBGUI

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.